
Survival Rates and Outlook for Acute Lymphocytic Leukemia (ALL)
Acute lymphocytic leukemia (ALL) is a fast-growing cancer primarily affecting children. It has high cure rates in this group, though survival rates are lower for adults but gradually improving.
Factors influencing survival rates include age at diagnosis, subtype of ALL, and how quickly a patient responds to treatment, with younger patients and certain subtypes generally having better outcomes. People with subtypes such as pre-B, common, or early pre-B generally have better outcomes compared to those with mature B-cell (Burkitt) leukemia or certain chromosomal abnormalities.
Coping strategies for ALL patients include seeking support from healthcare teams, utilizing resources from organizations like the Leukemia & Lymphoma Society, and considering complementary treatments to manage stress and improve quality of life.
What is acute lymphocytic leukemia (ALL)?
Acute lymphocytic leukemia (ALL) is a form of cancer. Each part of its name tells you something about the cancer itself:
Acute. The cancer is often fast-growing and requires early detection and treatment. Without treatment, bone marrow cells can't properly mature, and a person won't have enough healthy, mature bone marrow. Bone marrow is replaced by rapidly growing abnormal lymphocytes.
Lymphocytic. The cancer affects the lymphocytes of a person's white blood cells (WBCs). Another term that may be used is lymphoblastic.
Leukemia. Leukemia is a cancer of the blood cells.
Several types of ALL exist. The survival rates for ALL depend on what type a person has.
ALL is the most common childhood cancer, but it has high cure rates in children. Although survival rates aren't as high when it develops in adults, they're steadily improving.
What are the survival rates for ALL?
The National Cancer Institute (NCI) estimates 5,960 people will receive a diagnosis of ALL in the United States in 2018. About 1,470 people will die from the disease in 2018.
Several factors can determine survival rates, such as age at diagnosis and subtype of ALL.
The five-year survival rate in the United States is 68.1 percent, reports the NCI. However, these numbers are steadily improving. From 1975 to 1976, the five-year survival rate for all ages was under 40 percent.
Although most people who receive a diagnosis of ALL are children, the highest percentage of Americans with ALL who pass away are between the ages of 65 and 74.
In general, about 40 percent of adults with ALL are considered cured at some point during their treatment, estimates American Cancer Society. However, these cure rates depend on a variety of factors, such as the subtype of ALL and age at diagnosis.
A person is 'cured' of ALL if they're in complete remission for five years or more. But because there's a chance of the cancer coming back, doctors can't say with 100 percent certainty that a person is cured. The most they can say is whether or not there are signs of cancer at the time.
In children
According to the NCI, the five-year survival rate for American children with ALL is around 85 percent. This means that 85 percent of Americans with childhood ALL live at least five years after they receive a diagnosis with cancer.
Survival rates for ALL, especially for children, continue to improve over time as new treatments are developed.
Doctors may consider many of these children to be cured of their cancer if they've been in complete remission for more than five years. Remission means that there are reduced signs and symptoms of the cancer.
Remission can be partial or complete. In complete remission, you have no signs and symptoms of the cancer. ALL can return following remission, but treatment can begin again.
The NCI states that among American children with ALL, an estimated 98 percent achieve remission. Remission means a child doesn't have any signs or symptoms of the condition and blood cell counts are within normal limits.
What factors influence survival rate?
A number of factors can affect a person's survival rate following an ALL diagnosis, such as a person's age or WBC count at time of diagnosis. Doctors consider each of these factors when providing a person's outlook.
However, it's important to remember that this outlook is the doctor's estimation of survival given the diagnostic information they currently have.
What effect does age have on survival rate?
According to the NCI, some studies have found that people have a better chance of survival if they're 35 years old or under. In general, older adults with ALL will typically have a poorer outlook than younger people.
Children are considered higher risk if they're over age 10.
What effect does ALL type have on survival rate?
People with cell subtypes, including pre-B, common, or early pre-B, are generally considered to have better survival chances than those with mature B-cell (Burkitt) leukemia.
Chromosomal abnormalities
Many different types of ALL exist. The cancers that cause ALL can create different changes to a person's chromosomes. A doctor called a pathologist will examine the cancerous cells under a microscope.
Several different types of chromosomal abnormalities are associated with a poorer outlook. These include:
Ph1-positive t(9;22) abnormalities
BCR/ABL-rearranged leukemia
t(4;11)
deletion of chromosome 7
trisomy 8
If your doctor makes an ALL diagnosis, they'll tell you what type of leukemia cells you have.
What effect does treatment response have on survival rate?
People who respond quickly to treatments for ALL may have a better outlook. When it takes longer to reach remission, the outlook is often not as good.
If a person's treatment takes longer than four weeks to go into remission, this can affect their outlook.
What effect does the spread of ALL have on survival rate?
ALL can spread to the cerebral spinal fluid (CSF) in the body. The greater the spread to nearby organs, including CSF, the poorer the outlook.
What effect does WBC count have on survival rate?
Those with a very high WBC count at diagnosis (usually higher than 50,000 to 100,000) have a poorer outlook.
How can a person cope and seek support?
Hearing a doctor tell you that you have cancer is never easy. However, many types of ALL are highly treatable. While you undergo treatments, there are many avenues of support available to help you through this journey.
Some of the methods you can use are listed below:
Research the disease
Learning more from respected, well-researched organizations can help you become as informed as possible about your condition and care.
Examples of excellent resources include:
Leukemia & Lymphoma Society
American Cancer Society
Reach out to your healthcare team
Cancer treatment often involves a team approach to your care. Many cancer facilities have cancer navigators who can put you in touch with resources and support.
Many health professionals can support you or a loved one. They include:
psychiatrists
social workers
dietitians
child life specialists
case managers
chaplains
Consider complementary treatments
Treatments that promote relaxation and stress relief can complement your medical treatments. Examples could include massage or acupuncture.
Always talk to your doctor before beginning any complementary treatments such as herbs, vitamins, or special diets.
Create a share point for friends and loved ones
You'll likely encounter many people who would like to help or receive updates on how you're doing throughout your treatments.
If you're open to sharing these updates, consider webpages such as Caring Bridge. For friends who want to help, there are resources such as Meal Train. It allows friends to sign up for meal deliveries.
It's important to remember there are many friends, family members, and organizations who wish to help you in your treatment and recovery from ALL.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Washington Post
43 minutes ago
- Washington Post
The first drug to treat infants sick with malaria is approved by Swiss authority
GENEVA — Switzerland's medical products authority has granted the first approval for a malaria medicine designed for small infants, touted as an advance against a disease that takes hundreds of thousands of lives — nearly all in Africa — each year. Swissmedic gave a green light Tuesday for the medicine from Basel-based pharmaceutical company Novartis for treatment of babies with body weights between 2 and 5 kilograms (nearly 4½ to 11 pounds), which could pave the way for hard-hit African nations to follow suit in coming months.
Yahoo
an hour ago
- Yahoo
Why Oscar Health, Inc. (OSCR) Dipped More Than Broader Market Today
Oscar Health, Inc. (OSCR) closed the most recent trading day at $16.55, moving -1.55% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.07%. Meanwhile, the Dow experienced a drop of 0.37%, and the technology-dominated Nasdaq saw an increase of 0.03%. The company's stock has climbed by 13.89% in the past month, exceeding the Finance sector's gain of 2.38% and the S&P 500's gain of 3.94%. Market participants will be closely following the financial results of Oscar Health, Inc. in its upcoming release. The company is predicted to post an EPS of $0.34, indicating a 70% growth compared to the equivalent quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.86 billion, up 28.96% from the year-ago period. Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.61 per share and revenue of $11.21 billion. These totals would mark changes of +510% and +22.12%, respectively, from last year. Investors should also note any recent changes to analyst estimates for Oscar Health, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability. Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model. Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 11.11% downward. Right now, Oscar Health, Inc. possesses a Zacks Rank of #3 (Hold). In terms of valuation, Oscar Health, Inc. is presently being traded at a Forward P/E ratio of 27.41. This signifies a premium in comparison to the average Forward P/E of 9.99 for its industry. The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 145, placing it within the bottom 42% of over 250 industries. The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. To follow OSCR in the coming trading sessions, be sure to utilize Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Oscar Health, Inc. (OSCR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
The One Thing You Should Never, Ever Do in the Hour After Eating Lunch, According to a Cardiologist
The One Thing You Should Never, Ever Do in the Hour After Eating Lunch, According to a Cardiologist originally appeared on Parade. No matter what your health goals are, you likely start each day with the best of intentions. You have a healthy breakfast, full of fiber and protein. You enjoy a cup of coffee, which is known to support both brain and heart health. Maybe you even go for a walk or get a workout in. But by the time afternoon hits, it's easy for healthy habits to fall by the wayside. There's too much to do and not enough time, which can lead to doing (and eating) what's most convenient, even if it isn't healthy. And there's one common afternoon habit, in particular, that a cardiologist wishes people wouldn't do because it's detrimental to heart health. 🩺SIGN UP for tips to stay healthy & fit with the top moves, clean eats, health trends & more delivered right to your inbox twice a week💊 You're likely familiar with the afternoon slump. Typically, it happens about an hour after eating lunch. Blood sugar drops and tiredness sets in, making it hard to get through the rest of the day. To overcome it, many people turn to an energy drink. But Dr. Bhavna Suri, MD, a cardiologist with Manhattan Cardiology and contributor to LabFinder, wishes this habit would be left Suri explains that energy drinks can negatively impact heart health. 'Drinking these substances in excess sometimes speeds up our heart rate too much, or can cause some extra heartbeats, called ectopy,' she says, explaining that when this happens, it can lead to palpitations or a feeling of fluttering in the I'm a Cardiologist, and This 'Relaxing' Habit Is Actually Harming Your Heart Health Scientific research backs this up, showing that too much caffeine puts stress on the cardiovascular system, increasing the risk of arrhythmia. Other studies show that drinking energy drinks can cause blood pressure to go up. Drinking soda isn't any better. Scientific research shows that regularly drinking soda increases the risk of cardiovascular disease. Unfortunately, the same is true of diet soda. Another reason why Dr. Suri warns against using energy drinks to overcome an afternoon slump is because they can get in the way of getting a good night's sleep. Scientific research shows that not getting enough sleep on a regular basis increases the risk of cardiovascular disease. Related: Okay, so energy drinks and soda are out. What is a more heart-healthy way to get through the afternoon? Dr. Suri recommends taking a walk after lunch and getting some sunshine to help wake the body up. 'Incorporating a 15-minute walk [into your afternoon] can get blood circulating and can be good for your blood pressure and energy levels,' she says. Instead of downing an energy drink that can lead to heart palpitations, you'll be doing something that a wealth of scientific research has shown reduces the risk of cardiovascular Dr. Suri says that there's a way to craft your lunch in a way that will make experiencing an afternoon slump less likely. 'Having a protein-rich meal as opposed to high carbohydrates at lunch can improve energy levels,' she says. This is because simple carbs (like bread, chips, soda and pastries) increase blood sugar levels and then cause them to drop, which leads to a decrease in energy levels. But protein-based foods like chicken, tofu, beans and chickpeas don't spike blood sugar, which will keep energy levels more steady. Building an after-lunch walk into your daily routine is a way to keep your healthy habits going throughout the afternoon. By making a conscious effort to support your health in the morning and afternoon, you'll be more likely to keep it up in the evening too. Soon, your afternoon walk will become such an integral part of your routine that it will become automatic. And that's bound to benefit your heart both now and in the future. Up Next:Dr. Bhavna Suri, MD, a cardiologist with Manhattan Cardiology and contributor to LabFinder Effects of coffee/caffeine on brain health and disease: What should I tell my patients? Practical Neurology. 2016 Impact of Coffee Consumption on Cardiovascular Health. The Ochsner Journal. 2023 Effects of energy drinks on the cardiovascular system. World Journal of Cardiology. 2017 Energy Drink Consumption: Beneficial and Adverse Health Effects. International Journal of Health Sciences. 2015 The Impacts of Sugar-Sweetened Beverages (SSB) on Cardiovascular Health. Cureus. 2022 Diet Soft Drink Consumption is Associated with an Increased Risk of Vascular Events in the Northern Manhattan Study. Journal of General Internal Medicine. 2012 Sleep Duration as a Risk Factor for Cardiovascular Disease — a Review of the Recent Cardiovascular Reviews. 2010 Walking — the first steps in cardiovascular disease Opinion in Cardiology. 2011 The One Thing You Should Never, Ever Do in the Hour After Eating Lunch, According to a Cardiologist first appeared on Parade on Jul 8, 2025 This story was originally reported by Parade on Jul 8, 2025, where it first appeared.